atepeq/tico19 huggingface dataset:
about how long have these symptoms been going on?
muddo intee dhan ayay calaamadahan socdeen?
and all chest pain should be treated this way especially with your age
dhamaan feera xanuunka waa in loo daweeyo sidan gaar ahaan da'daada oo kale
and along with a fever
iyo ay weheliso qandho
and also needs to be checked your cholesterol blood pressure
sidoo kale waxaad u baahanyahay in lagaa hubiyo kolesteroolka dhiig karka
and are you having a fever now?
hadda qandho miyaad leedahay?
and are you having any of the following symptoms with your chest pain
miyaad leedahay mid ka mid ah calaamadaha soo socda la jiranka feedha xanuunkaaga
and are you having a runny nose?
miyaad leehady diif?
and are you having this chest pain now?
miyaad leedahay feera xanuunkan hadda?
and besides do you have difficulty breathing
intaa ka sokow dhib maku qabtaa neefsashada
and can you tell me what other symptoms are you having along with this?
oo ma ii sheegi kartaa calaamadaha kale ee aad la leedahay tan?
and does this pain move from your chest?
xanuunkan miyuu u wareegay laabtaada
and drink lots of fluids
cab dareere badan
and how high has your fever been
siday ahayd qandhadaada
and i have a cough too
waxaan leeyahay qufac sidoo kale
and i have a little cold and a cough
waxaan leeyahay xoggaa hargab ah iyo qufac
and i'm really having some bad chest pain today
runtiina maanta waxaan leeyahay xoogaa feera xanuun ba'an
and is this the right time for your hay fever
waa waqtigii ugu haboonaa ee samboorkaaga
and it get the chest pain
oo xanuun feeraha ah ayaa ku dhacay
and i think i have a little bit of a fever
waxaan u malaynayaa in aan leeyahay wax yar oo qandha ah
and i want you to describe where the chest pain is
waxaan rabaa in aad qeexdo mesha feeraha ka xanuunayaan
and she is sorta have the same symptoms
waxay qabtaa noocyo la mid ah calaamadahaas
and tell me what symptoms are you having now?
oo ii sheeg calaamado noocee aad hadda leedahay?
and they're having some fevers as well
sidoo kale waxay leeyihiin xoggaa qandhaha sidoo kale
and with your history of diabetes
iyo la jiranka taariikhdaada sokorawga ah
and you know it feels like my chest is like gonna crush
waad ogtahay waxaan dareemaa sidii in ay laabtu i dilaacayso
and you know people cough on me all the time
waad ogtahay dadka way igu qufacaan xilli kasta
and you're having chest pain
ma waxaad leedahay feera xanuun
and your symptoms do not go away in five days
calaamadahaaga maku dhamaanin shan maalin gudahood
and you said this is a pressure in your chest
waxaad na dhahdey waxaa ku leedahay cadaadis laabtaada
anyone in the family have a heart problem heart disease heart attack high cholesterol high blood pressure
qof kasta oo qoyska kamid oo qaba wadne xanuun cudduradda wadnaha dhibatooyin wadnaha ah kolesterool sare dhiig karka oo sare
any other symptoms or problems that you notice with the muscle aches?
calaamado ama dhibaatooyin kale oo aad ku aragto muruq xanuunka?
any sharp pain on your left side of your chest?
wax nabar ah oo kaa haya dhinaca bidixda ee laabtaada?
are there other people sick as you at home with your same symptoms?
majiraan dad kale oo u xanuunsan sidaada oo kale oo gurigaaga kula joogo oo leh calaamadahaaga oo kale?
are you having any difficulty breathing now
wax dhib ah maku qabtaa neefshada hadda
are you having any other symptoms?
miyaad leedahay wax calaamado oo kale?
are you having any shortness of breath?
miyaad leedahay wax neefshada oo yaraata ah?
are you still having the chest pain
wali miyaad leedahay xanuunkii feeraha
because this is flu season
sababtoo ah waa xilli hargabeed
besides the diabetes do you have other problems or important diseases?
kasokow sokorowga miyaad leedahay wax dhibaatooyin ah oo kale ama cuduro muhiim ah?
but also we shouldn't be put aside for the heart cardiac origin chest pain
lakiin sidoo kale waa in aan dhinac iska dhigin laab xanuun ka dhashay wadna xanuunka
but a more important problem now is this chest pain
lakiin dhibaato kale oo aad uga muhiimsan hadda waa feedha xanuunkan
but if you have the cough
lakiin hadaad qabto qufaca
but i have difficulty breathing
lakiin waxaan dhibaato ku qabaa neefshadada
but i know lot of people cough on me
lakiin waan ogahay dad badan ayaa igu qufucay
but we need to treat every chest pain with the utmost seriousness
lakiin waxaa la inooga baahanyahay in aan udaawayno feedha xanuun kasta daacadnimo midii ugu saraysay
but you're breathing all right right now right?
lakiin si fiican ayaad u neefsanaysaa hadda sax?
cause of this chest pain i totally forgot
feedha xanuunkan sababtiis gabi ahaanba waan hilmaamay
cause they're having a cough
sababtoo ah way qufacayaan
does it feel like somebody squeezing your chest
miyay dareentaa sidii qof ku hindhisaya laabtaada
do still feel like shortness of breath
wali dareema sidii in ay neefsashadu ku yartahay
do they complain of being sick similar symptoms?
miyay ka cabtaan in ay la xanuunsanyihiin calaamadaha la midka ah?
do you have any blood pressure problem as far as you know?
miyaad leedahay wax dhibaato dhiig kar ah ilaa xad inta aad ogsoontahay?
do you have any other chronic like high blood pressure or anything like that?
miyaad leedahay wax xanuun daba-dheeraday oo kale sida dhiig kar ama wax k?kasta oo kale oo la mid ah
do you have any other diseases chronic medical problems like diabetes?
miyaad qabtaa wax xanuun kale ah oo dhibaatadiisa daaweynd daba-dheeratay sida skorow?
do you have any shortness of breath with that chest pain?
miyaad qabtaa wax neefsasho la'aan ah la jiranka feedha xanuunkaas?
do you have high blood pressure?
miyaad qabtaa dhiig kar?
do you have some shortness of breath goes with that?
miyaad leedahay neefsasho yaraan oo taas la socota?
do you know what symptoms she was having?
miyaad ogtahay waxa ay tahay calaamadaha ay qabtay?
do your relatives have the same symptoms
qaraabadaada miyay qabaan calaamadahaas oo kale?
do you see the image?
ma aragtaa muqaalka?
drink plenty of fluids today
cab dareere badan maanta
have a dry cough a cold and runny nose vomiting diarrhea
wuxuu leeyahay qufac qalalan hargab iyo diif mataq shuban
however i take tests for the diabetes
si kasta ha ahaate waxaan qaadani baadhitaanada sokorow
however she has symptoms quite similar to mine
si kasta ha ahaate waxay leedahay calaamado la mid ah xoggaa kuwayga
how high is your fever?
intee in dhan ayay qandhadaada saraysaa?
how' s your blood pressure?
waa sidee dhiig karkaaga?
i don't think i have high blood pressure
uma malaynayo in aan qabo dhiig kar
i feel a pain in the chest here in the front part of the chest
xanuun ayaan ka dareemaa laabta halkan qaybta hore ee laabta
if you continue to have high fevers
haddii ay sii socoto in aad qabto qandho sareysa
if you have a fever of a hundred and two or higher
haddii aad qabto qandho ah boqol iyo labo ama ka kore
if you think that your symptoms or problems warrant a better look
haddii aad u malayso in ay calaamadahaaga ama dhibaatooyinkaaga mudanyihiin fiiro gaar ah
i got a fever yesterday
shalay qandho ayaan lahaa
i got a slight fever too
xoggaa yar oo qandha ah ayaa lahaa sidoo kale
i had a fever yesterday
qandho ayaan lahaa shalay
i had a short sharp pain in my chest
waxaan laabta iga qabanayay nabar yar
i have a sharp pain here in the chest
waxaan nabar ku leeyahay halkan laabta ah
i have hay fever though too
sidoo kale samboor ayaa qabaa in kastoo
i have made on the body around the chest area?
waxaan mariyay jidhka agaagaarka laabta?
i have some difficulty breathing too
sidoo kale waxaan xoggaa dhibaato kuqabaa neefsashada
i'll send you an image
waan kusoo diri doonaa muqaalka
i'm having some chest pain today
waxaan leeyahay xoggaa laab xanuun ah maanta
i'm just having some headaches and some fever today
waxaan leeyahay xoggaa yar oo madax xanuun ah iyo xoggaa qandha ah maanta
in my opinion it is flu
fikrad ahaantayda waxani waa hargab
in my opinion this is a little flu
fikrad ahaantayda waxani waa hargab yar
i see it going from the center of your chest going up to your neck
waxaan arkaa ayadoo ka wareegaysa bartamaha laabtaada korna ukoraysa luqantaada
is it like some heavy heavy person sitting on your chest?
waa sidii in qof aad iyo aad u culus u ku fadhiisanayo laabtayda
it all started with the headaches and with the fever about the same time
gabi ahaan waxay ku bilaabatay madax xanuunka iyo qandhada oo isku waqti ah
it hurts in the chest
way dhaawacaysa laabta
it hurts in the middle of my chest
waxay dhaawacaysaa bartamaha laabtayda
it is a pressure like chest pain
waa cadaadis sida feedha xanuunka oo kale
it is in my chest
waxay ku jirtaa laabtayda
it is in the center of my chest
waxay kku jirtaa bartamaha laabtayda
it is in the center of the chest
waxay kujirtaa bartamaha laabta
it is occurring right in the middle of my chest
waxay dhacaysaa dhinaca midig ee bartamaha laabtayda
it is right in the center of my chest
waxay kujirtaa dhinaca midig ee bartamaha laabtayda
it sounds like you just may have the garden variety cold or a flu
waxay u eegtahay iin aad qabto qabaw ba'an oo noocyo badan ama hargab
i've got pain in my chest
waxaan xanuun ku lahaa laabtayda
i've very concerned of this chest pain
aad ayaan ugu walaacsanahay feedha xanuunkan
i want you to tell me in describing this chest pain
waxaan ka rabaa in aad isheegto adigoo qeexayo feedha xanuunkan
i will send you an image
waan kusoo diri muqaal
i will send you an image on your screen
muqaal ayaan kusoo diri doonaa shaashadaada
like high blood pressure or diabetes
sidii dhiig kar oo kale ama sokorow
like right in the center of the chest
sidii in ay dhinaca midig ee bartamaha laabtayda
most of the time it is this type of chest pain
inta badan waxaa waaye noocan feedha xanuunka ah
my sister has similar symptoms
walaashay waxay qabtaa calaamadahan oo kale
now for the fever you can take a tachipirina sweet
hadda qandhada waxaad uqaadan kartaa tachipirina macaan
now i send you an image
hadda ayaan kusoo dirii muqaaal
now mary how many days have you had the symptoms
hadda mary imisa maalmood ayaad lahayd calaamadaha
now you said you have a chest pain
hadda waxaad dhahday in aad qabto feedha xanuun
occasionally i have some chest pain
mar mar ka qaar waxaan leeyahay xoggaa feedha xanuun ah
okay are you having any other symptoms along with this other than just the pain
hagaag ma waxaad leedahay calaamado kale la jiranka kuwaan oo aan ahayn xanuunka
or if you have high blood pressure
ama haddii aad qabto dhiig kar
or somebody sitting on your chest?
ama qof ayaa kaga fadhiisanaya laabtaada?
pretty much the same with the fever and the cough headache and muscle pains
hagaag in ka badan oo la mid ah qandhada iyo qufaca madax xanuunka iyo murqo xanuunka
right in the middle of my chest
dhinaca midig ee bartamaha laabtayda
show me on this image where you feel the pain
muqaalka iga tus meesha aad ka dareento xanuunka
since you have a fever
ilaa inta aad lahayd qandhada
so do you think that some of these symptoms could be related to being pregnant?
sidaas awgeed miyaad u malaynaysaa in ay qayb calaamadahan ka mid ah la xariiraan in aad tahay uur?
so your chest pain started this morning
sidaas awgeed feedha xanuunkaagu wuxuu bilawday saaka
so your children are having some of the same symptoms?
sidaas awgeed caruurtaadu ma waxay qabaan qayb calaamadahan oo kale ah?
tell me about your chest pain
wax iga sheeg feedha xanuunkaaga
the fever increases at night
qandhada habeenkii ayay siyaadaa
the fever i've had for the last two days
qandhada aan qabay labadii maalin ee lasoo dhaafay
the fever started to increase last night
qandhada waxay bilawdaa in ay siyaado xalay
the fever started two days ago
qandhada waxay bilaabatay laba maalin ka hor
the muscle pains with the hay fever
murqo xanuun oo leh samboor
this is doctor porter in the emergency room triage center
kani waa dhaqtar porter oo ku jira qolka xaaladaha dag daga ah ee xarunta kal soocida bukaanada
well can you tell me a little bit more about your chest pain?
hagaag ma iga sheegi kartaa xogga yar oo dheerad oo ku saabsan feedha xanuunkaaga?
well from my point of view it is a little flu
hagaag fikir ahaantayda waxan waa hargab yar
well i feel a pain in the front of my body here in my chest
hagaag waxaan xanuun ka dareema qaybta kore ee jidhkayga halkan laabtayda
well i've been having a strong pain in my chest
hagaag waxaan lahaa feedhaha xanuun aad u xoogan
well madam from listening to your symptoms it sounds like you've got one of the flu viruses
hagaag marwo marka dhagaystay calaamadahaaga waxay u eegtahay in aad qaaday fayruusyada hargabka
well when i have that pain in my chest
hagaag xilliga aan xanuunkaas ku leeyahay laabtayda
what kinda pain do you have in your chest?
hagaag xanuun nooce ah ayaad ku leedahay laabtaada?
when this chest pain started?
gorma ayuu feedha xanuunkan bilawday?
where do you have the pain in the chest?
halkee ayaad feedha xanuunka ku leedahay?
where you feel this chest pain eel this chest t
halka aad ka dareento feedha xanuunkan eel laabta t
you are probably having chest pain
waxaa macquul ah in aad qabto feedha xanuun
you feel like tightness on your chest
waxaad ka dareentaa feedhahaaga in ay isku dhaga yaan
you know i got diabetes and stuff
waad ogtahay waxaan lahaa sokorow iyo arimahaas
you said you're having this chest pain
waxaad dhahday waxaad leedahay feedha xanuunkan
Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
Faafitaanta xawliga ah ee dhacdooyinka guud ee kiisaska cudurka coronavirus (COVID-19) ee gudaha Midawga Yurub/Aaga Dhaqaale ee Yurub iyo Boqortooyada Ingiriis, 1dii Janaayo ilaa 15ka Maarso 2020
The cumulative incidence of coronavirus disease (COVID-19) cases is showing similar trends in European Union/European Economic Area countries and the United Kingdom confirming that, while at a different stage depending on the country, the COVID-19 pandemic is progressing rapidly in all countries.
Dhacdooyinka guud ee kiisaska coronavirus (COVID-19) ayaa muujinaya isbadalo la mid ah Midawga Yurub/Aaga Dhaqaale ee Yurub iyo Boqortooyada Ingiriiska oo xaqiijiyay midaas, halka marxaladdo kala gadisan oo ku xidhan wadanka, cudurka caalamiga ah ee COVID-19 ayaa si xawli ah ugu faafaya dhamaan wadanada.
Based on the experience from Italy, countries, hospitals and intensive care units should increase their preparedness for a surge of patients with COVID-19 who will require healthcare, and in particular intensive care.
Ayadoo la tixraacayo khibrada laga helay Talyaaniga , wadanada, isbitaalada iyo qeybaha daryeelka dagdagga ah waa in ay kordhiyaan diyaar garawgooda ah in ay daba galaan bukaanada qaba COVID-19 kuwaas oo u baahaan daryeel caafimaad, gaar ahaan daryeelka dagdagga ah.
On 31 December 2019, a cluster of pneumonia cases of unknown aetiology was reported in Wuhan, Hubei Province, China.
31kii Diseembar 2020, koox kiisas burunkiito ah oo aan la aqoon asalkooda ayaa laga sheegay Wuhan, Gobalka Hubei, Shiinaha.
On 9 January 2020, the China Center for Disease Control and Prevention reported the causative agent as being a novel coronavirus now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
9kii Janaayo 2020, Xarunka Xakamaynta iyo ka Hortaga Cuduradda ee Shiinaha ayaa sheegtay waxa sababa coronavirus cusub oo hadda la yiraahdo xanuunka ba'an ee habka neefsashada ee calaamadaha coronavirus 2(SARS-CoV-2).
Since, the illness resulting from SARS-CoV-2 infection has been named coronavirus disease (COVID-19).
ilaa intii, xanuunka ka dasha caabuqa SARSA-CoV-2 lagu magacaabay cudurka coronavirus (COVID-19).
Evidence to date is that ca 80% of individuals with COVID-19 have a mild disease, i.e. a respiratory tract infection with or without pneumonia, and most of these recover.
Cadaynta ilaa ayaa in ca 80% dadka qaba COVID-19 ay leeyihiin xanuun yar, sida caabuqa kudhaca habka neefsashada ee la jiranka ama la jiritaan la'aanta burunkiito, inta badana way ka bogsadaan
In ca 14% cases, COVID-19 develops into a more severe disease requiring hospitalisation while the remaining 6% cases experience critical illness requiring intensive care.
ca 14% kiisas, COVId-19 ayaa u hormaraya xanuun aad u ba'an oo u baahnaanaya daaweyn halka 6% kiisaska soo hartayna ay la tacaalaan xanuun halis ah oo u baahnaanaya daryeel dag dag ah.
The mortality of patients hospitalised due to COVID-19 is ca 4%.
Dhimashada bukaanada la dawaynayo ee COVID-19 waa ca 4%.
In this study, we assess the trends in the cumulative incidence of COVID-19 in each European Union/European Economic Area (EU/EEA) country and the United Kingdom (UK) and compare them to that of Hubei Province, China.
daraasaddan, waxaan qiimaynaynaa isbadalada dhamaan dhacdooyinka COVID-19 ee wadan kasta oo Midawga Yurub ah/Aaga Dhaqaale ee Yurub (EU/EEA) iyo Boqortooyada Ingiriiska (UK) oo aan la barbar dhigno Gobalka Hubei. Shiinaha.
We also compare the current number of COVID-19 cases in EU/EEA countries and the UK with that in Italy during 31 January–15 March 2020.
Sidoo kale waxaan barbar dhigaynaa tirada hadda ee kiisaska COVID-19 ee gudaha wadanada Midawga Yurub/Aaga Dhaqaale ee Yurub UE/EEA iyo Boqortooyada Ingiriiska UK iyo mida Talyaaniga inta lagu jiro 31 Janaayo-15 Maarso 2020
COVID-19 cases in EU/EEA countries and the UK
Kiisaska COVID-19 ee gudaha wadamada Midawga Yurub/Aaga Dhaqaale ee Yurub EU/EEA iyo Boqortooyada Ingiriiska UK
Subsequent to China, COVID-19 underwent further geographical spread and the dynamic of the COVID-19 pandemic in the rest of the world currently follows that of this country.
Kaddib Shiinaha, COVID-19 wuxuu ku faafay dhul badan juquraafi ahaan xawligga cudurka saf-mareenka ah ee COVID-19 ee inta kale aduunka hadda waa mid la mid ah sida kan wadankan
On 11 March 2020, the Director General of the World Health Organization (WHO) declared COVID-19 a pandemic.
11Maarso 2020, Agaamisha Guud ee Hay'ada Caafimaadka Aduunka (WHO) wuxuu u aqoonday COVID-19 cudur caalami ah
In the 5 March issue of Eurosurveillance 2020, Spiteri et al. reported on the first European confirmed COVID-19 cases according to the WHO case definition.
5tii maarso arinta Eurosurveilance 2020, Spiteri et al. waxay sheegtay kiiskii ugu horeegay ee COVID-19 ee Yurub sida ay qeexday Hay'ada Caafimaadka Aduunka WHO
In the EU/EEA, the first three confirmed cases were reported by France on 24 January 2020 in persons returning from Wuhan, Hubei Province, China.
Gudaha Midawga Yurub/Aaga Dhaqaale ee Yurub EU/EEA, saddexda kiis ee ugu horeeyay ee la xaqiijiyay ayaa laga sheegay 24tii Janaayo 2020 qof kasoo laabanayay Wuhan, Gobalka Hubei, Shiinaha.
As at 15 March 2020, COVID-19 cases had been detected in all 30 EU/EEA countries and the United Kingdom (UK), whereby between 31 December 2019 and that date included, 39,768 cases and 1,727 deaths had been reported, with 17,750 cases and 1,441 deaths from Italy alone.
15kii Maarso 2020, kiisaskii ugu horeeyay ee COVID-19 ayaa lagu wada arkay dhamaan 30 ka dal ee Midawga Yurub/Aaga Dhaqaale ee Yurub EU/EEA iyo Boqortooyada Ingiriiska (UK), halka intii u dhaxaysay 31 Diseembar 2019 iyo tariikhdaas la xusay, la shaaciyay 39,768 kiis iyo 1,727 dhimasho, la jranka 17,750 kiis iyo 1,441 dhimasho oo Talyaaniga kali ah.
Obtaining cumulative number and cumulative incidence of COVID-19 cases
Helida tirada guud iyo dhacdooyinka guud ee kiisaska COVID-19
At the European Centre for Disease Prevention and Control (ECDC), the notified COVID-19 case counts in each country worldwide, obtained from only official sources such as the countries’ Ministry of Health, national and regional health authorities and the WHO, are updated each day at 8:00 a.m.
Xarunta ka Hortaga iyo Xakamaynta Cuduradda ee Yurub (ECDC), tirada kiisaska COVID-19 ee la shaaciyayee wadan kasta oo aduunka ah, oo laga helay illo rasmi ah oo kali ah sida wasaaradaha caafimaadka ee wadaanka, madaxda caafimaad ee heer qaran iyo heer gobol ba iyo Hay'ada Caafimaadka aduunka WHO, ayaa maalin kasta la shaaciyaa abaarihii 8:00 am
These data were used for assessing the trends of COVID-19 in EU/EEA and the UK, and comparing them to that in Italy.
Macluumaadkan waxaa loo adeegsaday qiimaynta isbadallada COVID-19 ee gudaha EU/EEA iyo UK iyo in lala barbar-dhigo mida Talyaaniga.
As a proxy of the prevalence of active COVID-19 cases, we calculated the 14-day truncated cumulative incidence of COVID-19 cases, thus taking into account the natural course of COVID-19, in each EU/EEA country and the UK, during the 1 January–15 March 2020 period.
Sida madaxda tabinta kiisaska dadka ku dhacay COVID-19, waxaan xisaabinay 14 maalin ee la gaabiyay dhacdooyinka guud ee kiisaska COVID-19, sidaas awgeed ayadoo lagu xisaabtamayo koorsada dabiiciga ah ee COVID-19 ee wadan kasta oo a tirsan EU/EEA iyo UK, inta lagu jir mudada 1 Janaayo-15 Maarso 2020.
We also presented the cumulative number of notified cases of each country as at 15 March 2020 8:00 a.m. compared with that of Italy for the 31 January–15 March 2020 period.
Waxaan soo bandhignay tirada guud ee kiisaska la ogaaday ee wadanka kasta 15kii Maarso 2020 8:00 a.m. marka la barbar dhigay mida Talyaaniga mudadda 31 Janaayo-15 Maarso 2020.
Trends of COVID-19 in EU/EEA countries and the UK
Isbadallada COVID-19 ee gudaha wadanada EU/EEA iyo UK
The trends in the 14-day truncated cumulative incidence of COVID-19 cases in EU/EEA countries and the UK generally followed that of Hubei Province (China) (Figure 1).
Isbadalada 14 ka maalin dhacdooyinka guud ee lasoo gaabiyay ee kiisaska COVID-19 ee gudaha wadamada EU/EEA iyo UK ayaa guud ahaan ku socda mida Gobalka Hubei (Shiinaha) (jaantuska 1).
For the EU/EEA and the UK overall, the cumulative incidence of COVID-19 started to increase around 21 February and then increased sharply around 28 February 2020 (Supplementary material).
Guud ahaan EU/EEA iyo UK, dhacdooyinka guud ee kiisaska COVID-19 ayaa bilawday in ay kordhaan ku dhawaadka 21 Febraayo oo hadana si xawli ah ku kordhay ku dhawaadkii 28 Febraayo 2020 (Shay kaalmooti ah).
This was mostly driven by the rapid increase in the number of reported cases from Italy, but all other EU/EEA countries and the UK showed similar increasing trends of the cumulative incidence of COVID-19 (Supplementary material).
Midan waxay ka laga keenay faafitaanka xawliga ah ee tirada kiisaska laga shaaciyay Talyaaniga, lakiin dhamaan wadamada kale ee EU/EEA iyo UK ayaa muujinaya isbadal kordhaya ee tirada guud ee dhacdooyinka COVID-19 (Shay kaalmooti ah).
Figure 2 shows the cumulative number of COVID-19 cases, in EU/EEA countries and the UK compared with that in Italy for the 31 January–15 March 2020 period.
Jaantuska 2 wuxuu muujinaya tirada guud ee kiisaska COVID-19, ee gudaha wadamada EU/EEA iyo UK oo la barbar-dhigay mida Talyaaniga laga bilaabo mudada 31 Janaayo-15 Maarso 2020
It highlights that, as at 15 March 8:00 a.m., 15 other EU/EEA countries and the UK had already reported a total number of cases comparable to that of Italy just 3 weeks prior or less.
Waxay tusinaysaa in, 15kii Maarso 8:00 a.m., in 15 wadan oo kale oo ka mid EU/EEA iyo UK ay horaan shaaciyeen tirada guud ee kiisaska oo la barbar-dhigi karo mida Talyaaniga 2 isbuuc ka hor ama ka yar uun.
Our results indicate that the number of notified cases of COVID-19 is rapidly increasing in the EU/EEA and the UK.
Natiijadayadu waxay tusaysaa in tirada la ogaaday ee kiisaska COVID-19 in ay si xawli ah ku kordhayaan gudaha EU/EEA iyo UK.
The observed trends in the cumulative incidence of COVID-19 suggest that the pandemic is progressing at a comparable speed in all countries.
Isbadadllada la arkay ee dhacdooyinka guud ee COVID-19 waxay soo jeedinaysaa in cudurkan caalamiga ah oo ku faafayo xawli la is barbar-dhigi karo dhamaan wadanada.
This is despite countries being at different stages, variations in national public health responses, and possibly different case definitions in countries and different protocols for selecting patients that must be tested for confirmation of COVID-19, including catch-up testing.
Tani waxay imaanaysaa iyadoo dalalku ay kukala duwanyihiin heerarka, kala duwanaashaha ka jawaabista caafimaadka dadwaynaha ee qaran, iyo suurtagalnimada qeexitaanka kiisaska kala duwan ee dalalka iyo maamuusyada kala duwan ee xulashada bukaanada ay tahay in la baaro si loo xaqiijiyo COVID-19, ee ay kamid tahay baaritaanka la qabsashada.
Early March 2020, doctors in the affected regions of Italy described a situation in which ca 10% of patients with COVID-19 required intensive care and media sources reported that hospitals and intensive care units in these regions had already reached their maximum capacity.
Horaantii Maarso 2020, dhakhaatirta jooga gobollada uu saameeyay ee Talyaaniga ayaa sheegay xaalad taas oo 10% bukaanada uu hayo COVID-19 ay u baahnaayeen qaybta daryeelka degdegga halka ilaha warbaahintu ay soo tabiyeen in isbitaalada iyo qalabka daryeelka ee goballadani ay gaadheen meeshii ugu saraysay ee qaadi kareen.
Data on admission of COVID-19 cases in a hospital and/or an intensive care unit are currently available at EU/EEA level for only 6% and 1% cases, respectively (data not shown).
Xogta diwaangelinta kiisaska COVID-19 ee isbitaallada iyo/mise qaybta daryeelka degdegga ah in hadda laga heli karo heerka EU/EEU oo kali ah kiisaska 6% iyo 1%, siday isugu xigaan(xogta lama muujin).
They should, however, be collected in a systematic fashion to complement current surveillance data that focus on the number of reported cases and the number of deaths.
Waa in, si kasta ha ahaatee, loo uruuriyaa qaab nidaamsan si loogu baddelo xogta indha ku haynta ee hadda taas oo diirada saarta tirada kiisaska lasoo sheegay iyo tirada dhimashooyinka.
A study performed in 2010–11 showed a large variation in the availability of intensive care and intermediate care beds in Europe, ranging from 29.2 in Germany to 4.2 beds per 100,000 population in Portugal.
Daraasad la sameeyay 2010-11 ayaa muujisay kala duwanaan baahsan ee helitaanka daryeelka degdegga iyo sariiraha daryeelka dhexe ee Yurub, iyadoo u dhaxaysa 29.2 Jarmalka ilaa 4.2 sariirood 100,000 qofba bulshada Burtaqiiska.
This means that countries may have more or less resources than Italy (12.5 intensive care and intermediate care beds per 100,000 population in 2010–11).
Tani waxay ka dhigantahay in dalalka ay lahaan karaa dakhli ka badan ama ka yar midka Talyaaniga (12.5 daryeelka degdegga iyo sariiraha daryeelka dhexe ee 100,000 ee qofba bulshada intii lagu jiray 2010-11)
Modelling scenarios related to healthcare capacity saturation, with estimates for each EU/EEA country and the UK of the prevalence of hospitalised COVID-19 cases associated with a &gt; 90% risk of exceeding intensive care bed capacity, are provided in the sixth update of the ECDC rapid risk assessment on COVID-19.
Marxaladaha naqshadaynta ee la xiriira isu gaynta xajmiga daryeelka caafimaadka, oo leh qiyaaso dal walba oo ka tirsan EU/EEA iyo Boqortooyada Ingiriiska ee mudnaan siinta kiisaska isbitaalka la dhigay ee COVID-19 ee la xiriira a > 90% khatarta xad dhaafitaanka mugga sariirta daryeelka degdegga, ayaa lagu muujiyay cusboonaysiinta lixaad eee ECDC qiimaynta khatarta degdegga ee COVID-19.
Since cases have so far clustered in certain regions in EU/EEA countries and the UK, and hospitals and intensive care units usually serve a defined regional catchment population, information about cases and intensive care beds should preferably be made available at the Nomenclature of territorial units for statistics 2 (NUTS-2) level.
Maadaama kiisaska ilaa xad ay korayaan gobollada qaarkood ee dalalka EU/EEAiyo Boqortooyada Ingiriiska, iyo isbitaallada iyo qaybaha daryeelka degdegga oo caadiyan u adeega la qabsiga bulsho gobol oo qeexan, macluumaadka kusaabsan kiisaska iyo sariiraha daryeelka degdegga waa in laga dhigaa kuwa si mudnaan ah laga heli karo aaga Magacbixinta qaybaha tirakoobka 2 (NUTS-2)heerka.
The experience from Italy and the current trends in other countries show that the COVID-19 pandemic is progressing rapidly in the EU/EEA and the UK.
Khibrada Talyaaniga iyo jihooyinka hadda ee dalalka kale ayaa muujinaya in cudurka caalamiga ee COVID-19 uu hor ugu socdo si xawli ah EU/EEA iyo Boqortooyada Ingiriiska.
Countries, hospitals and intensive care units should thus prepare themselves for a scenario of sustained community transmission of SARS-CoV-2 and an increase in the number of patients with COVID-19 requiring healthcare, and in particular intensive care, such as the one occurring in the affected regions of Italy.
Dalalka, Isbitaalada iyo qaybaha daryeelka degdegga waa inay isu diyaariyaan marxallad ah isu gudbinta bulshada joogtaysan ee SARS-CoV-2 iyo kor u kaca tirada bukaanada uu hayo COVID-19 ee u baahan daryeel caafimaad, iyo gaar ahaan daryeelka degdegga, sida kan ka dhacaya gobollada uu saameeyay ee Talyaaniga.
As pointed out in the recent ECDC rapid risk assessment, a rapid, proactive and comprehensive approach is essential to delay the spread of SARS-COV-2, with a shift from a containment to a mitigation approach, as the anticipated rapid increase in the number of cases may not provide decision makers and hospitals enough time to comprehend, accept and adapt their response accordingly if not implemented ahead of time.
Sida lagu xusay qiimaynta khatarta xawliga ah ee dhawaan, la tacaalitaan xawli ah, shaqaynaya oo dhamaystiran ayaa aasaasi u ah si loo dib dhigo fiditaanka SARS-COV-2, iyadoo laga guurayo habka xakamaynta laguna wareegayo yaraynta, iyadoo kor u kaca xawliga ah ee la la rajaynayo ee tirada kiisaska laga yaabo inaysan siin karin go'aan gaarayaasha iyo isbitaalada wakhti ku fulan oo ay ku fahmaan, aqbalaan ayna kula qabsadaan falcelintooda si waafaqsan hadii aan la dhaqan gelinin waqti ka hor.
The rapid risk assessment also lists the public health measures to mitigate the impact of the pandemic.
Qiimaynta khatrta xawliga ah wuxuu sidoo kale liiska ku darayaa talaabooyinka caafimaadka bulshada si loo yareeyo saamaynta cudurka caalamiga ah.
There is a short window of opportunity during which countries have the possibility to further increase their control efforts to slow down the spread of SARS-CoV-2 and decrease the pressure on healthcare.
Waxaa jira fursad yar oo ay dalalka ay haystaan suurtagalnimo ay kor ugu sii qaadi karaan dadaaladooda xakamayn si ay hoos ugu dhigaan fiditaanka SARS-COV-2 ayna hoos ugu dhigaan cadaadiska saaran daryeelka caafimaadka.
Failing this, it is likely that the healthcare systems of other EU/EEA countries will face a surge of patients that require intensive care within the coming days or weeks.
Fashilitaanka tan, waxay u badantahay in nidaamyada daryeelka caafimaad ee dalalka kale ee EU/EEA ay wajihi doonaankor u kac wayn ee bukaanada u baahan daryeel degdegga maalmaha mise todobaadyada soo socda.
The outbreak of Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), has thus far killed over 3,000 people and infected over 80,000 in China and elsewhere in the world, resulting in catastrophe for humans.
Dilaacitaanka xanuunka Coronavirus 2019 (COVID-19), ee uu sababay calaamada xanuunka neefmareenka ba'an (SARS) coronavirus 2 (SARS-CoV-2), ayaa ilaa hadda dilay in ka badan 3,000 oo qof wuxuuna ku dhacay in ka badan 80,000 gudaha Shiinaha iyo meelaha kale ee caalamka, kaasoo sababay musiibo bini'aadmi.
Similar to its homologous virus, SARS-CoV, which caused SARS in thousands of people in 2003, SARS-CoV-2 might also be transmitted from the bats and causes similar symptoms through a similar mechanism.
Si lamid ah fayruuskeeda u eg, SARS-CoV, kaas oo sababay SARS kumanaan qof intiii lagu jiray 2003, SARS-CoV-2 ayaa sidoo kale ka gudbi kara fiidmaaraha oo sababaya calaamado lamid ah iyadoo uu marayo qaab lamid ah.
However, COVID-19 has lower severity and mortality than SARS but is much more transmissive and affects more elderly individuals than youth and more men than women.
Si kastaba ha ahaatee, COVID-19 wuxuu leeyahay ba'naan iyo dhimasho hoosaysa marka loo eego SARS laakiin way ka gudbitaan badantahay waxayna saamaynaysaa inta badan dadka waawayn marka loo fiiriyo dhalinyarta iyo rag badan marka loo fiiriyo haweenka.
In response to the rapidly increasing number of publications on the emerging disease, this article attempts to provide a timely and comprehensive review of the swiftly developing research subject.
Ka falcelinta tirada sida xawliga ah u kordhaysa ee daabacaadaha cudurada soo ifbaxaya, maqaalakani wuxuu isku dayayaa inuu keeno aragti dhamaystiran oo waqti leh oo ku saabsan mawduuca cilmi baarista sida fudud u hormaraya.
We will cover the basics about the epidemiology, etiology, virology, diagnosis, treatment, prognosis, and prevention of the disease.
Waxaan daboolaynaa aasaaska ku saabsan culuumta cudurada faafa, asal ahaanta cudurka, fayruus barashada,baaritaanka, daweynta, saadaalinta sababaha xanuunka, iyo ka hortaga xanuunka.
Although many questions still require answers, we hope that this review helps in the understanding and eradication of the threatening disease.
Inkastoo sua'aalo badan ay wali u baahanyihiin jawaabo, waxaan rajaynaynaa in aragtidan ay caawiso fahanka iyo cidhib tirka xanuunka hanjabaya.
The Spring Festival on January 25, 2020 has become an unprecedented and unforgettable memory to all Chinese who were urged to stay indoors for all the holiday and for many weeks after due to the outbreak of a novel viral disease.
Xaflada guga ee Janaayo 25, 2020 waxay ku noqotay xasuus aan horay loo arag oona la hilmaamayn dhamaan Shineeska kuwaas oo loo sheegay inay guryaha ku jiraan fasaxa oo dhan todobaadyo badan kadib markuu dilaacay xanuunka fayruuska cusub.
The virus is highly homologous to the coronavirus (CoV) that caused an outbreak of severe acute respiratory syndrome (SARS) in 2003; thus, it was named SARS-CoV-2 by the World Health Organization (WHO) on February 11, 2020, and the associated disease was named CoV Disease-19 (COVID-19).
Fayruuska wuxuu si wayn ugu egyahay coronavirus (CoV) kaas oo sababay dilaaca xanuunka calaamadaha neefmareenka ba'an(SARS) intii lagu jiray 2003; sidaa daraadeed, waxaa lagu magacaabay SARS-CoV-2 oo ay yeeshay Hay'ada Caafimaadka Aduunka(WHO) Febraayo 11, 2020, iyo xanuunka la xiriirana waxaa lagu magacaabay CoV Xanuun-19(COVID-19).
The epidemic started in Wuhan, China, and quickly spread throughout the entire country and to near 50 others all over the world.
Xanuunka safmareenku wuxuu ka bilawday Wuhan, Shiinaha, wuxuna si dhakhsa ah ugu faafay dalka oo dhan iyo in ku dhaw 50 kale oo daafaha caalamka ah.
As of March 2, 2020, the virus has resulted in over 80,000 confirmed cases of COVID-19, with more than 40,000 patients discharged and over 3,000 patients who died.
Ilaa Maarso 2, 2020, fayruuska wuxuu sababay in ka badan 80,000 kiisas la xaqiijiyay oo COVID-19 ah, iyadoo in ka badan 40,000 oo bukaan ay ka bogsoodeen in ka badan 3,000 oo bukaana ay u dhinteen.
WHO warns that COVID-19 is “public enemy number 1” and potentially more powerful than terrorism.
Hay'ada Caafimaadka aduunka waxay ka digaysaa in COVID-19 uu yahay "cadawga 1aad ee bulshada" uuna suurtagalyahy inuu ka awood badanyahay argagixisanimada.
According to PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), in less than two months, over 200 papers have been published on COVID-19 including its virology, epidemiology, etiology, diagnosis, and treatment since the first report on January 7, 2020 that determined the sequence of the virus isolated from multiple patients.
Sida laga soo xigtay PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), wax ka yar laba bilood, in ka badan 200 oo waraaq ayaa laga daabacay COVID-19 oo ay kamid tahay culuumtiisa fayruuska, barashadiisa culuumta faafta, barashada asalkiisa, baaritaankiisa, iyo daaweyntiisa ilaa iyo markii ugu horaysay ee lasoo sheegay Janaayo7, 2020 kaas oo muujiyay isku xigitaanka sida fayruuska loogu karaantiilay dhawr bukaan.
This review attempts to summarize the research progress in the new and swiftly developing subject area.
Tafatirkan wuxuu isku dayayaa inuu soo koobo hor u socodka cilmi baarista ee aaga mawduuca cusub ee sida fudud u hormaraya.
Whenever possible, we will try to compare COVID-19 with SARS and another CoV-caused disease, Middle East respiratory syndrome (MERS, an outbreak in 2012).
Marwalaba oo suurtagal ah, waxaan isku dayaynaa inaan COVID-19 barbardhigno SARS iyo xanuun kale uu sababayCoV, Xanuunka neefmareenka ee Bariga Dhexe (MERS, oo dilaacay 2012).
We will also discuss what we have learned so far regarding the prevention and prognosis of the disease as well as some remaining yet urgent questions.
Waxaan sidoo kae ka hadli doonaa waxaan ilaa hadda baranany iyadoo la tixgalinayo ka hortga iyo saadaalinta sababaha xanuunka iyo sidoo kale su'aalo kale oo harsan oo weliba degdeg ah.
CoVs have been traditionally considered nonlethal pathogens to humans, mainly causing approximately 15% of common colds 4.
CoVs waxaa si dhaqan ahaan ah loogu yaqaanay caabuq aan bin'aadanka dilin, isagoo inta u badan sababaya wax ku dhaw 15% ee hargabyada 4.
However, in this century, we have encountered highly pathogenic human CoVs twice, i.e., SARS-CoV and MERS-CoV, which caused an outbreak originally in China in 2003 and Saudi Arabia in 2012, respectively, and soon spread to many other countries with horrible morbidity and mortality.
Si kastaba ha ahaatee, qarnigan, waxaan la kulanay cudur keenaha bini'aadamka CoVs oo wayn laba mar, sida SARS-CoV iyo MERS-CoV, kuwaas oo sababay dilaacitaan uu ka bilawday Shiinaha 2003 iyo Sacuudiga 2012, siday isugu xigaan, oo si dhakhsa ah ugu fiday dalal kale oo badan isagoo lahaa caafimaad darro xun iyo dhimasho.
Therefore, the current COVID-19 is the third CoV outbreak in the recorded history of humans.
Sidaa daraadeed, COVID-19 hadda waa dilaacitaanka CoV kii saddexaad ee taariikhda bini'aadanka la diwaan galiyay.
As shown in Fig. ​Fig.1,1, clusters of pneumonia that had unknown origins were first reported from Wuhan on December 31, 2019 to the China National Health Commission.
Sida lagu muujiyay Jaantuuska 1,1, kooxaha koolba'aariyada kuwaas oon faracooda la aqoon ayaa markii ugu horaysay laga soo sheegay Wuhan Diseembar 31, 2019 oo ku aadanayd Guddiga Caafimaadka qaran ee Shiinaha.
Seven days later the sequence of the CoV was released.
Toddobo maalin kadib siduu isugu xigo CoV ayaa lasoo daayay.
On January 15, 2020 the first fatal case from Wuhan was reported.
Janaayo 15, 2020 dhimashadii ugu horaysay Wuhan ayaa lasoo sheegay.
Meanwhile, the epidemic rapidly spread to the neighboring cities, provinces, and countries.
Isla wakhtigii, xanuunka safmareenku wuxuu si xawli ah ugu faafay magaalooyinka dariska la ah, gobollada iyo dalalaka.
On January 20, the infection of health-care providers was reported, suggesting that human-to-human transmission was possible.
Janaayo 20, xanuun qaaditaanka daryeelayasha caafimaadka ayaa lsoo sheegay, taas oo soo jeedinaysa in bini'aadamku isu gudbiyo ay suurtagal tahay.
On January 23, the city of Wuhan was locked down with all its public transportation stopped.
Janaayo 23, magaalada Wuhan ayaa xayiraad lagu soo rogay iyadoo dhamaan gaadiidka dadwaynaha la joojiyay.
On January 24 the first clinical study on the disease reported that, out of 41 patients with confirmed cases, only 21 had direct contact with the Wuhan seafood market that was considered the starting site of the infection from an unknown animal source.
Janaayo 24 daraasadii caafimaad ee xanuunka ee ugu horaysay ayaa sheegtay, in 41 bukaan ee ah kiisaska la xaqiiyay, kali ah 21 ayaa taabasho toos ah la lahyd suuqa cuntada badda ee Wuhan kaas oo loo mlaynayo inuu yahay goobta uu ka billawdo caabuqu khayraad xoolo oon la garanayn.
On January 30, WHO declared the outbreak a global health emergency.
Janaayo 30, Hay'ada caafimaadka aduunka waxay ku dhawaaqday inuu dilaacitaanku yahay xaalad caafimaad oo degdegga caalamka oo dhan
By the time of this report, the disease has already spread throughout China and near 50 other countries all over the world (Fig. ​(Fig.2).2).
Waqtiga warbixintan, xanuunka wuxuu ku faafay Shiinaha iyo ku dhawaad 50 dal oo daafaha caalamka ah(Jaantuuska 2)
As the situation is rapidly evolving, the final scope and severity of the outbreak remain to be determined.
Maadaama xaaladu si xawli ah ay isu bedelayso, ballaca ugu dambeeya iyo ba'naanta dilaacitaanka waxay yihiin kuwa jooga.
On February 11, 2020, a multi-center study on 8,866 patients including 4,021 confirmed COVID-19 patients presented a more updated illustration of the epidemic as follows (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Febraayo 11, 2020, daraasad xarumo badan oo lagu sameeyay 8,866 bukaan oo ay kamid yihiin 4,021 bukaan oo COVID-19 laga xaqiijiyay ayaa soo bandhigay muuqaal si badan loo cusboonaysiiyay oo ku saabsan xanuunka safmarka ah sida soo socota (https://mp.weixin.qq.com/s/UIBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 infected people of all ages, but mainly at the age of 30-65.
SARS-CoV-2 dadka uu ku dhacay ee da' kasta leh, laakiin ugu badnaan da'da 30-65.
Almost half (47.7%) of the infected individuals were over 50 years old, very few were under 20, and only 14 infected individuals were under the age of 10.
Ku dhawaad kalabar (47.7%) ee dadka uu ku dhacay waxay ka waynaayeen 50 sano, wax aad u yar ayaa ka yaraa 20, kali ah 14 dadkii uu ku dhacay ayaa ka yaraa da'da 10.
SARS-CoV-2 infected more men (0.31/100,000) than women (0.27/100,000).
SARS-CoV-2 wuxuu ku dhacay rag badan (0.31/100,000) marka loo barbardhigo haweenka (0.27/100,000).
COVID-19 expanded in clusters mainly in and around Hubei.
COVID-19 wuxuu u fiday kooxo inta ugu badan gudaha iyo agagaarka Hubei.
COVID-19 took an average of 5 (2-9) days from onset to diagnosis.
COVID-19 wuxuu qaatay celcelis 5 (2-9) maalmood ku dhicitaanka ilaa baaritaanka.
The average incubation period was 4.8 (3.0-7.2) days.
Celceliska mudada uu haynayo waxay ahayd 4.8 (3.0-7.2) maalmood.
The average time from onset to death was 9.5 (4.8-13) days.
Celceliska waqtiga uu ku dhacay ilaa dhimashada waxay ahayd 9.5(4.8-13) maalmood.
The basic reproductive number (R0) was 3.77 (95% CI: 3.51-4.05), and the adjusted R0 was 2.23-4.82.
Tirada taranka aasaasiga ah (RO) waxay ahayd 3.77 (95% Cl: 3.51-4.05), iyo RO la badellay wuxuu ahaa 2.23-4.82.
The number of infected people increased exponentially before 23 Jan. 2020, matching the time of massive transportation before the Spring Festival in China.
Tirada dadka xanuunka qaaday kor ayay u kacday si xawli ah ka hor 23 janaayo. 2020, iyadoo ku aadan waqtiga gaadiidka xad dhaafka ah ee xaflada guga ee Shiinaha.
The mortality of patients with confirmed cases was 1.44% (95% CI: 1.10-1.86%), and the adjusted mortality of all the patients was 3.06% (95% CI: 2.02-4.59%).
Dhimashada bukaanada leh kiisaska la xaqiijiyay waxay ahayd 1.44% (95% CI: 1.10-1.86%), iyo mida wax laga bedellay ee dhimashada bukaanada waxay ahayd 3.06% (95% CI: 202-4.59%).
Three major risk factors for COVID-19 were sex (male), age (≥60), and severe pneumonia.
Saddex qodob oo khatar wayn ku ah COVID-19 waxay ahaayeen galmada (labka), da'da (>=60), iyo kolba'aariyada xumaatay.
CoVs are a subfamily of large and enveloped viruses containing a single strand of sense RNA.
CoVs waa qoys hoosaad katirsan fayruusyo waawayn oo dahaadhan kuwaas oo ka kooban hal xarigle dareenka RNA.
They can be divided into four genera, i.e., alpha, beta, gamma, and delta, of which alpha- and beta-CoVs are known to infect humans.
Waxaa loo qaybin karaa afar qaybood, sida, alpha, beta, gamma iyo delta, kuwaas oo alpha iyo betalagu yaqaan inay ku dhacaan bina'aadanka.
The envelope spike (S) glycoprotein binds to its cellular receptors angiotensin-converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) for SARS-CoV and MERS-CoV, respectively, and then membrane fusion occurs.
Xuubka sare(S) glycoprotein wuxuu ku dhagayaa unugeeda dareemaha angiotensin-baddelaha enzyme 2 (ACE2) iyo dipeptidyl peptidase 4 (DPP4) ee loogu talagalay SARS-CoV iyo MERS-CoV, siday isugu xigaan, kadibna xuub isu imaatinka ayaa dhaca.
The viral RNA genome is released into the cytoplasm; after replication of the viral genome, genomic RNA accompanied by envelope glycoproteins and nucleocapsid proteins forms virion-containing vesicles, which then fuse with the plasma membrane to release the virus.
Genome RNA ee fayruuska leh waxaa lagu sii daayaa cytoplasm; kadib tarmida fayruuska genome, genomic RNA uu weheliyo xuubka.
The first genomic sequence of SARS-CoV-2 was reported on January 10, 2020.
isku xigitaanka ugu horeeya genomic SARS-CoV-2 waxaa lasoo sheegay Janaayo 10, 2020.
SARS-CoV-2 was found to be a new type of beta-CoV with more than 99.98% genetic identity among 10 sequenced samples collected from the original site of the outbreak, the Huanan Seafood Market in Wuhan.
SARS-CoV-2 waxaa la ogaaday inuu yahay nooc cusub oo beta-CoV oo leh in ka badan 99.98% aqoonsiga genematic oo ka tirsan 10 tijaabo oo isku xiga oo laga soo aruuriyay meeshii ugu horaysay uu ka dilaacay, suuqa cuntada badda ee Huanan ee ku yaala Wuhan.
SARS-CoV-2 is genetically more similar to SARS-CoV than to MERS-CoV.
SARS-CoV-2 hidda ahaan wuxuu u egyahay SARS-CoV marka loo barbardhigo MERS-CoV
Through transmission electron microscopy, SARS-CoV-2 particles were found in ultrathin sections of human airway epithelium.
Iyadoo loo marayo gudbinta elektaroonka maykraskoobka, dhibcaha SARS-CoV-2 waxaa lagu arkay qayb aad u dhuuban oo xuubka neefmareenka bin'aadanka ah.
Human ACE2 was found to be a receptor for SARS-CoV-2 as well as SARS-CoV.
ACE2 bini'aadanka waxaa la ogaaday inuu yahay qabtaha SARS-CoV-2 iyo sidoo kale SARS-CoV.
However, the S protein of SARS-CoV-2 binds to human ACE2 more weakly than that of SARS-CoV, which is coincident with the fact that SARS-CoV-2 causes less severe infection in patients than SARS-CoV.
Si kastaba ha ahaatee, borotiinka S ee SARS-CoV-2 wuxuu ku dhagayaa ACE2 bini'aadanka si aad uga daciifsan SARS-CoV, taas oo la babacdhacaysa xaqiiqada ah in SARS-CoV-2 uu sababo caabuq halis yar bukaanada marka loo eego SARS-CoV.
SARS-CoV-2 can also form a novel short protein encoded by orf3b and a secreted protein encoded by orf8.
SARS-CoV-2 wuxuu sidoo kale samaysan karaa borotiin gaaban oon caadi ahayn oo uu la socdo orf3b iyo borotiin layska soo saaray oo uu la socdo orf8.
The orf3b of SARS-CoV-2 may play a role in the viral pathogenicity and inhibit the expression of IFNβ; however, orf8 does not contain any known functional domain or motif.
orf3b ga SARS-CoV-2 wuxuu door ka ciyaari karaa caabuqnimada fayruuska iyo inuu xayiro qeexitaanka IFNB; si kastaba ha ahaate, orf8 kuma jiro meel la garanayo oo shaqaynaysa mise ueedo.
On February 18, 2020, Zhou, et al., reported the cryo-EM structure of the full-length human ACE2 at 2.9 Å resolution in complex with the amino acid transporter B0AT1.
Febraayo 18, 2020, Zhou, et al., waxay soo sheegtay qaabka cryo-EM oo dheerar buuxa ACE2 bini'aadanka meesha 2.9 A iskudarka la walaaqay ee aashitada amino gudbisa B0AT1.
They found that the complex, which had open and closed conformations, was assembled as a dimer and the ACE2-B0AT1 complex can bind two S proteins, which provides evidence for CoV recognition and infection.
Waxay ogaadeen in isku jirka, kaas oo furay hadana xiray xaqiijimooyinka, waxaan isugu gaynay isku jirka sidii mid daciif ah iyo ADCE2-B0AT1 waxay isugu dhagi karaan labo borotiinka S ah, kaas oo tusa cadaynta aqoonsiga CoV iyo caabuqa.
B0AT1 may become a therapeutic target for drug screening to suppress SARS-CoV-2 infection.
B0AT1 wuxuu noqon karaa bartilmaameed daawayn ee baarista daawada si loo xannibo caabuqa SARS-CoV-2.
The origin and intermediate host
Xanuun qaadaha asalka ee uu kasoo bilawdey iyo kan dhexe.
It has been known that both SARS-CoV and MERS-CoV originated from bats and were transmitted to humans via civet cats and camels, respectively.
waxaa la ogaaday in labadaba SARS-CoV iyo MERS-CoV ay kasoo farcameen fiidmaarta loona gudbiyay bini'aadanka iyadoo loo marayo bisadaha iyo geela siday isugu xigaan.
Through a phylogenetic comparison of SARS-CoV-2 with other CoVs, bats were considered the native host of SARS-CoV-2 as the new virus is 96% identical to two SARS-like CoVs from bats called bat-SL-CoVZX45 and bat-SL-CoVZX21.
Iyadoo loo marayo isbarbardhiga taariikhda faraca noolaha ee SARS-CoV-2 iyo CoV yada kale, fiid-merrta ayaa loo aqoonsaday xanuun qaadaha asalka ah ee SARS-CoV-2 maadaama uu fayruuska cusub uu 96% la midyahay labo SARS-CoV ahaan oo kale ah oo laga helay fiid-meeraha oo lagu magacaabay fiid-meer-SL-CoVZX45 iyo fiidmaar-SL-CoVZX21.